Esophageal Cancer

CStone Pharmaceuticals and Blueprint Medicines Corporation announced the first patient dosed in a phase 1b/2 trial of fisobatinib in combination with CS1001 for the treatment of locally advanced or metastatic hepatocellular carcinoma, according to a press release.

Researchers developed a deep-learning, computer aided system that detected neoplasia in patients with Barrett’s esophagus at a better rate than nonspecialized endoscopists, according to study results.

BARCELONA, Spain — Nivolumab extended survival compared with chemotherapy among patients with advanced or recurrent esophageal squamous cell carcinoma regardless of PD-L1 expression, according to results of the randomized phase 3 ATTRACTION study presented at European Society for Medical Oncology Congress.

Endoscopic submucosal dissection with traction assistance helped reduce procedure time and avoid adverse events in patients with large esophageal cancers, according to study results.